Prehypertension and the cardiometabolic syndrome: targeting several risk factors to achieve maximum benefit

Niki Katsiki; Michael Doumas; Vasilios G Athyros; Asterios Karagiannis

doi:10.1586/14779072.2014.890051

Prehypertension and the cardiometabolic syndrome: targeting several risk factors to achieve maximum benefit

Expert Rev Cardiovasc Ther. 2014 Mar;12(3):295-6. doi: 10.1586/14779072.2014.890051. Epub 2014 Feb 10.

Authors

Niki Katsiki¹, Michael Doumas, Vasilios G Athyros, Asterios Karagiannis

Affiliation

¹ Second Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippocration Hospital, Thessaloniki, Greece.

PMID: 24506503
DOI: 10.1586/14779072.2014.890051

Abstract

Response to: Duprez D, Toleuova A. Prehypertension and the cardiometabolic syndrome: pathological and clinical consequences. Expert Rev Cardiovasc Ther 2013;11(12):1725-33.

Publication types

Letter
Comment

MeSH terms

Cardiovascular Diseases / prevention & control*
Humans
Hypertension / therapy*
Prehypertension / therapy*